鲁抗医药
(600789)
| 流通市值：77.09亿 | | | 总市值：79.75亿 |
| 流通股本：10.10亿 | | | 总股本：10.45亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,879,642,638.45 | 2,110,032,099.52 | 2,344,308,789.62 | 786,358,617.39 |
| 交易性金融资产 | - | - | 0 | 0 |
| 应收票据及应收账款 | 961,433,391.5 | 961,310,208.86 | 748,512,673.19 | 955,387,979.32 |
| 应收账款 | 961,433,391.5 | 961,310,208.86 | 748,512,673.19 | 955,387,979.32 |
| 应收款项融资 | 273,623,989.37 | 141,039,851.52 | 267,158,630.02 | 442,313,517.64 |
| 预付款项 | 43,699,745.6 | 67,327,224.31 | 28,400,170.76 | 63,181,322.18 |
| 其他应收款合计 | 246,948,147.97 | 254,492,207.02 | 264,823,268.87 | 265,429,271.26 |
| 存货 | 1,310,549,357.37 | 1,248,844,492.52 | 1,247,390,887.6 | 1,266,992,024.09 |
| 其他流动资产 | 73,224,593.43 | 43,489,591.75 | 50,260,448.18 | 34,784,197.7 |
| 流动资产合计 | 4,789,121,863.69 | 4,826,535,675.5 | 4,950,854,868.24 | 3,814,446,929.58 |
| 非流动资产: | | | | |
| 长期股权投资 | 62,067,419.72 | 63,666,978.66 | 64,876,001.93 | 66,985,599.84 |
| 其他权益工具投资 | 15,614,567.89 | 14,936,305.34 | 15,390,578.96 | 15,818,043.94 |
| 投资性房地产 | 51,494,778.6 | 52,298,260.4 | 53,101,595.49 | 45,291,528.9 |
| 固定资产 | 3,564,790,468.97 | 3,651,300,670.25 | 3,660,309,716.46 | 3,521,977,199.92 |
| 在建工程 | 290,512,103.22 | 195,064,411.61 | 239,745,251.07 | 285,773,023.24 |
| 无形资产 | 796,916,547.28 | 774,936,278.63 | 786,788,695.72 | 778,340,228.64 |
| 开发支出 | 124,246,309.9 | 131,544,253.97 | 123,617,574.04 | 167,167,181.92 |
| 长期待摊费用 | 1,447,864.66 | 1,598,160.31 | 1,759,742.98 | 953,666.74 |
| 递延所得税资产 | 42,592,046.3 | 40,652,513.31 | 40,517,925.5 | 22,718,937.5 |
| 其他非流动资产 | 113,914,183.83 | 130,571,478.09 | 97,089,118.92 | 96,894,822.21 |
| 非流动资产合计 | 5,063,596,290.37 | 5,056,569,310.57 | 5,083,196,201.07 | 5,001,920,232.85 |
| 资产总计 | 9,852,718,154.06 | 9,883,104,986.07 | 10,034,051,069.31 | 8,816,367,162.43 |
| 流动负债: | | | | |
| 短期借款 | 723,492,931.93 | 915,511,855.95 | 1,108,005,648.05 | 1,038,320,911.92 |
| 应付票据及应付账款 | 1,464,392,874.91 | 1,262,925,721.31 | 1,047,883,671.18 | 1,105,138,118.26 |
| 其中：应付票据 | 558,701,657.32 | 336,195,460.03 | 123,043,000 | 255,858,000 |
| 应付账款 | 905,691,217.59 | 926,730,261.28 | 924,840,671.18 | 849,280,118.26 |
| 预收款项 | 43,672.55 | 571,541.17 | 47,342.38 | - |
| 合同负债 | 69,681,500.85 | 83,183,698.8 | 82,810,567.54 | 71,765,164.08 |
| 应付职工薪酬 | 20,453,466.67 | 19,752,605.89 | 24,830,130.52 | 16,745,419.93 |
| 应交税费 | 42,722,747.99 | 54,374,296.03 | 49,298,084.03 | 24,040,215.96 |
| 其他应付款合计 | 233,272,069.97 | 208,747,640.78 | 205,305,183.64 | 204,721,333.01 |
| 应付股利 | 2,683,705.49 | 1,680,905.49 | 1,680,905.49 | 2,683,705.49 |
| 一年内到期的非流动负债 | 409,744,399.81 | 594,983,035.22 | 872,298,798.12 | 723,382,257.89 |
| 其他流动负债 | 7,212,731.24 | 7,787,535.1 | 7,759,566.32 | 6,556,019.82 |
| 流动负债合计 | 2,971,016,395.92 | 3,147,837,930.25 | 3,398,238,991.78 | 3,190,669,440.87 |
| 非流动负债: | | | | |
| 长期借款 | 1,192,008,000 | 1,137,850,000 | 1,089,140,000 | 1,241,790,000 |
| 长期应付款 | 2,000,000 | 2,000,000 | 2,000,000 | 123,857,705 |
| 递延收益 | 286,716,104.29 | 282,585,940.24 | 288,027,696.59 | 155,220,624.46 |
| 非流动负债合计 | 1,480,724,104.29 | 1,422,435,940.24 | 1,379,167,696.59 | 1,520,868,329.46 |
| 负债合计 | 4,451,740,500.21 | 4,570,273,870.49 | 4,777,406,688.37 | 4,711,537,770.33 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,045,189,778 | 1,045,189,778 | 1,045,189,778 | 898,669,632 |
| 资本公积 | 2,738,493,120.42 | 2,738,446,286.56 | 2,738,446,286.56 | 1,698,137,293.88 |
| 其他综合收益 | -24,385,432.11 | -25,063,694.66 | -24,609,421.04 | -24,181,956.06 |
| 专项储备 | 1,831,234.66 | 1,652,655.49 | 1,546,046.83 | 1,419,858.77 |
| 盈余公积 | 212,098,421.8 | 212,098,421.8 | 212,098,421.8 | 207,388,115.67 |
| 未分配利润 | 1,280,136,601.33 | 1,195,242,748.24 | 1,141,989,364.93 | 1,175,591,052.2 |
| 归属于母公司股东权益合计 | 5,253,363,724.1 | 5,167,566,195.43 | 5,114,660,477.08 | 3,957,023,996.46 |
| 少数股东权益 | 147,613,929.75 | 145,264,920.15 | 141,983,903.86 | 147,805,395.64 |
| 股东权益合计 | 5,400,977,653.85 | 5,312,831,115.58 | 5,256,644,380.94 | 4,104,829,392.1 |
| 负债和股东权益合计 | 9,852,718,154.06 | 9,883,104,986.07 | 10,034,051,069.31 | 8,816,367,162.43 |
| 公告日期 | 2026-08-29 | 2026-04-25 | 2026-04-25 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |